Fluorescence In Situ Hybridization (FISH) Imaging Systems Market By Product (Instruments, Consumables & Accessories, Services, Software), By Application Outlook (Cancer Diagnosis, Genetic Disease Diagnosis, Others), By End-use (Diagnostic Laboratories, Research & Academic Institutes and Others) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa) – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data and Forecasts 2022 – 2028

Fluorescence In Situ Hybridization (FISH) Imaging Systems Market Overview

FISH (fluorescence in situ hybridization) is a cytogenetic technique that uses fluorescent chromosomal probes to show sequence complementarity. To determine where the fluorescent probe is linked to the chromosome, fluorescence microscopy is utilised. This technology allows researchers to visualise and outline the genetic material in a single cell, including specific genes or sections of genes, in a novel way. FISH is an important method for diagnosing chromosomal abnormalities and other genetic alterations.
In the field of in-vitro diagnostics, technologically sophisticated products are also driving the market. For example, one of the significant advances responsible for increased demand for FISH imaging equipment is the introduction of 3D FISH technology. It allows for three-dimensional imaging and analysis of target cells, increasing the likelihood of successful study outcomes. Positive research outcomes, shorter procedure times, ease of use, and higher probe labelling efficiency are just a few of the advantages of using FISH imaging, which is expected to drive up demand.
 

Market Size

According to Business Intelligence Insights "Fluorescence In Situ Hybridization (FISH) Imaging Systems Market is expected to grow from USD 693.70 million  in 2021 to USD 1094.71 million  by 2028, at a CAGR of 7.90 % during the forecast period 2022-2028

Covid -19 Impact Analysis

The COVID-19 pandemic has wreaked havoc on people's lives and companies. It's now a global pandemic that's infected practically every country on the planet and ruined a number of market functions. Full lockdown and social distancing rules required to be enforced at processing facilities, R&D centres, and other company divisions. Labor shortages, infrastructure, and transportation limits have all had a negative influence on supply chains, resulting in manufacturing losses and revenue drops. Similarly, demand for fluorescence in situ hybridization (FISH) imaging equipment declined in the first half of 2020. Fluorescence in situ hybridization (FISH) is a macromolecule identification technique that takes advantage of the complementary nature of DNA/RNA or DNA double strands. In the fourth quarter of 2020, COVID-19 had a beneficial impact on the market. 

Market Dynamics

In the field of in-vitro diagnostics, technologically sophisticated products are also driving the market. For example, one of the significant advances responsible for increased demand for FISH imaging equipment is the introduction of 3D FISH technology. It allows for three-dimensional imaging and analysis of target cells, increasing the likelihood of successful study outcomes. Positive research outcomes, shorter procedure times, ease of use, and higher probe labelling efficiency are just a few of the advantages of using FISH imaging, which is epected to drive up demand.

Segmentation Insights

By Product 

 Imaging Systems was dominated by instrument with more than 30% share  

   In 2021, the market for Fluorescence In Situ Hybridization (FISH) Imaging Systems was dominated by instrument with more than 30% share  The market for instrument has been increased due to adoption of imaging systems such as microscopes, spectrophotometers, and others. Furthermore, due to greater acceptance and cost-efficiency, services are predicted to develop dramatically during the forecast period.

 

By Application 

The cancer hold the largest share more than 45 %

   The applications in which Fluorescence In Situ Hybridization (ISH) Imaging Systems can be taken are Cancer Diagnosis, Genetic Disease Diagnosis and Others. The cancer hold the largest share more than 45 %. Cancer diagnostics took up a significant portion of the application category. This is due to an increase in the occurrence of diseases including cancer and genetic disorders. Furthermore, the increased demand for accurate, sensitive, and speedy cancer diagnosis is projected to drive this segment's growth. Furthermore, an increasing number of large companies' research endeavors for the development of advanced systems are likely to expand the market's potential. 

By Product 
•    Instruments
•    Consumables & Accessories
•    Services
•    Software

By Application 
•    Cancer Diagnosis
•    Genetic Disease Diagnosis
•    Others

By End-user
•    Diagnostic Laboratories
•    Research & Academic Institutes
•    Others

By Region
•    North America
o    U.S.
o    Canada
•    Europe 
o    Germany
o    U.K.
o    France
o    Italy
o    Spain
o    Rest of Europe
•    Asia Pacific 
o    China
o    India
o    Japan
o    Rest of Asia Pacific
•    Latin America 
o    Brazil
o    Mexico
o    Rest of Latin America
•    Middle East and Africa 
o    UAE
o    South Africa
o    Rest of Middle East and Africa (MEA)

Key Players

List of Key Players in the Global Fluorescence In Situ Hybridization (FISH) Imaging Systems Market:

•    BIOVIEW
•    West Medica Produktions- und Handels- GmbH
•    PerkinElmer, Inc.
•    Leica Biosystems Nussloch GmbH
•    Bio-Rad Laboratories, Inc.
•    BioTek Instruments, Inc.
•    GE Healthcare
•    Thermo Fisher Scientific, Inc.
•    TissueGnostics GmbH
•    Applied Spectral Imaging
•    MetaSystems
•    MR Solutions

Regional Insights

North America owned the lion's share of the market. Collaborations between key companies are forming to expand product portfolios and increase revenue share, which is a major element driving growth in this region. This region's dominant position is also due to extensive research and innovative product development by big players. For the period of the forecast, the Asia Pacific is expected to make significant improvement. This can be attributed to rising healthcare costs and increased awareness among investigators and pathologists about the diagnostic benefits of this method. Furthermore, a majority of the market's notable organizations are continually supporting acceptance of these approaches over various inventiveness, which is expected to increase demand in the field.

Increasing awareness in developing markets such as China and India, combined with widespread financial advancement in these countries, is expected to offer up significant potential opportunities in this industry.

Table

Report Attributes	Details
Market Size Value in 2021	USD 693.70 million
Market Size Value in 2028	USD 1094.71 million
Growth Rate	+7.90 %
Base Year	2021
Forecast Period	2021-2030
Historical Data	2018-2020
Forecast Units	(USD Million)
Countries Covered	North America, U.S., Canada, Europe, Germany, U.K., France, Italy, Spain, Rest of Europe, Asia Pacific, China, India, Japan, Rest of Asia Pacific, Latin America, Brazil, Mexico, Rest of Latin America, Middle East and Africa, UAE, South Africa, Rest of Middle East and Africa (MEA)
Segments Covered	By Product, By Application, By End User, By Region
Competitive landscape	Leading companies, Competitive strategies and Consumer engagement scope
Customization is available	If our report does not contain the information you require, you can contact our experts to have segments created for you. Please contact us at sales@businessintelligence-insights.com if you have any questions

 

Frequently Asked Questions (FAQ):